9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,213 | -4,955 | -3,121 | -1,881 | -8,741 |
| Depreciation Amortization | 1,837 | 838 | 756 | 229 | 993 |
| Accounts receivable | -365 | -437 | -513 | 279 | 2,746 |
| Accounts payable and accrued liabilities | -753 | -633 | 445 | 560 | -677 |
| Other Working Capital | -3,647 | -2,659 | -85 | 794 | 4,941 |
| Other Operating Activity | 714 | 1,609 | 366 | -728 | -992 |
| Operating Cash Flow | $-8,427 | $-6,237 | $-2,152 | $-747 | $-1,730 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 641 | 581 | 605 | 392 | 7,002 |
| Debt Issued | 406 | 406 | 406 | 406 | 4,600 |
| Debt Repayment | -462 | -462 | N/A | N/A | N/A |
| Common Stock Issued | 8,824 | 8,151 | N/A | N/A | 2,969 |
| Other Financing Activity | 352 | 412 | 1,174 | -128 | -12,819 |
| Financing Cash Flow | $9,761 | $9,088 | $2,185 | $670 | $1,752 |
| Beginning Cash Position | 119 | 119 | 119 | 119 | 97 |
| End Cash Position | 1,453 | 2,970 | 152 | 42 | 119 |
| Net Cash Flow | $1,334 | $2,851 | $33 | $-77 | $22 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,427 | -6,237 | -2,152 | -747 | -1,730 |
| Free Cash Flow | -8,427 | -6,237 | -2,152 | -747 | -1,730 |